Nadel B, Marculescu R, Le T, Rudnicki M, Böcskör S, Jäger U
Department of Internal Medicine I, University of Vienna, Austria.
Leuk Lymphoma. 2001 Nov-Dec;42(6):1181-94. doi: 10.3109/10428190109097743.
The t(14:18)(q32:q21) chromosomal translocation and the ensuing overexpression of the BCL-2 proto-oncogene are strongly associated with the pathogenesis of follicular lymphoma. At the molecular level, the translocation process arises from the illegitimate rearrangement between the BCL-2 proto-oncogene and the immunoglobulin heavy chain (IgH) locus. Due to the presence of the D(H) and J(H) gene segments from the IgH locus as well as de novo nucleotide additions at the breakpoints, the translocation process has been assumed to result from a mistake occurring during V(D)J recombination in early B-cells in the bone marrow. However, recent detailed molecular analyses of both the direct and reciprocal breakpoints have revealed that the t(14;18) translocation is a more complex process than previously thought, and have challenged this traditional view. Here we review these observations, and discuss the intriguing possibility that t(14;18) translocation could preferentially occur in the germinal centers during receptor revision, and involves both V(D)J recombination and somatic hypermutation mechanisms.
t(14:18)(q32:q21)染色体易位以及随之而来的BCL-2原癌基因的过表达与滤泡性淋巴瘤的发病机制密切相关。在分子水平上,易位过程源于BCL-2原癌基因与免疫球蛋白重链(IgH)基因座之间的非法重排。由于IgH基因座中存在D(H)和J(H)基因片段以及断点处的从头核苷酸添加,易位过程被认为是由骨髓中早期B细胞V(D)J重组过程中发生的错误导致的。然而,最近对直接和相互断点的详细分子分析表明,t(14;18)易位是一个比以前认为的更复杂的过程,并对这一传统观点提出了挑战。在这里,我们回顾这些观察结果,并讨论t(14;18)易位可能在受体修正期间优先发生在生发中心,并且涉及V(D)J重组和体细胞超突变机制这一有趣的可能性。